Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Head and Neck Cancers
•
Radiation Oncology
Do you employ a phrenic nerve dose constraint with conventional fractionation?
E.g. breast or H&N cancers when boosting the supraclav area.
Answer from: Radiation Oncologist at Academic Institution
No.
Sign in or Register to read more
14494
Related Questions
How do you consider the role of probiotics for mucositis mitigation in patients receiving head and neck radiotherapy?
What is your radiation dose/volume for adjuvant treatment of a clear cell odontogenic carcinoma of the mandible after segmental resection?
What is your approach to reporting mandible dose received to the dentist/oral surgeon?
What dose and fractionation would you use for Kaposi’s sarcoma of the tonsil post op?
How would you determine ipsilateral vs bilateral neck irradiation for early stage, well lateralized nasal cavity SCC?
Are any centers routinely using 55 Gy in 20 fractions with chemotherapy for definitive treatment of head and neck cancer following presentation of the HYPNO study?
Do you recommend radioactive iodine for Hürthle Cell thyroid carcinoma?
What is the recommended adjuvant dose for neuroendocrine cancer in the head and neck?
How would you approach an early stage p16+ SCC of the tonsil s/p TORS and neck dissection with initial positive margins but then negative on re-resection?
For locally advanced adenocarcinoma of the maxillary sinus, how should the neck be managed?